MALLORY WIPF: Open Payments
NPI 1417405416 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 48 payments from 12 companies in 2025. Trend: 2023 $18 · 2024 $151 · 2025 $987
Food & beverage: $827Education: $160
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $232 |
| SANOFI-AVENTIS U.S. LLC | 2 | $160 |
| GlaxoSmithKline, LLC. | 7 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| CSL Behring | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Genentech USA, Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $31 |
Products named: DUPIXENT, Hizentra, TRELEGY ELLIPTA, CUVITRU, Xolair, FASENRA, NUCALA, NEFFY.
Industry payments across SD — which companies pay providers there.
